By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ImmunoCellular Therapeutics, Ltd 



Los Angeles  California    U.S.A.
Phone: Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
ImmunoCellular Therapeutics, Ltd (IMUC) Announces Issuance Of Key Patent For ICT-107 Cancer Vaccine 12/17/2014 8:01:31 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Receives Positive Regulatory Feedback From European Medicines Agency On Advancing ICT-107 To Phase 3 Program 12/1/2014 8:51:15 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Presents Updated ICT-107 Phase 2 Data at the Society for Neuro-Oncology Annual Meeting 2014 11/14/2014 7:23:31 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Announces Third Quarter 2014 Financial Results 11/10/2014 8:02:40 AM
ImmunoCellular Therapeutics, Ltd (IMUC) To Present At Livingston Securities Conference On October 1, 2014 9/26/2014 10:12:25 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Expands Cancer Immunotherapy Platform With Antigen-Specific T-Cell Technology Licensed From California Institute of Technology 9/24/2014 7:43:45 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Receives Positive Regulatory Feedback On ICT-107 Supporting Advancement To Registrational Phase 3 Testing In Newly Diagnosed Glioblastoma 9/17/2014 8:21:27 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Announces Second Quarter 2014 Financial Results 8/8/2014 8:07:10 AM
ImmunoCellular Therapeutics, Ltd (IMUC) To Report Financial Results For The Second Quarter 2014 On August 7, 2014 7/30/2014 8:45:36 AM
ImmunoCellular Therapeutics, Ltd (IMUC) Presents Updated ICT-107 Phase II Data In Patients With Newly Diagnosed Glioblastoma At The 2014 American Society of Clinical Oncology Annual Meeting 6/2/2014 6:44:44 AM
12345678910...
//-->